Vγ2Vδ2 T-cell receptor-mediated recognition of aminobisphosphonates

Blood

Volumn 98, Issue 5, 2001, Pages 1616-1618

  Das, Hiranmoy ^a   Wang, Lisheng ^a   Kamath, Arati ^a   Bukowski, Jack F ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; ETIDRONIC ACID; PAMIDRONIC ACID; RISEDRONIC ACID; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; ANTIGEN; DRUG DERIVATIVE; GAMMA INTERFERON; HYBRID PROTEIN; INTERLEUKIN 2; LYMPHOCYTE ANTIGEN RECEPTOR;

ANTIGEN RECOGNITION; ARTICLE; BONE METASTASIS; CONTROLLED STUDY; CYTOLYSIS; DRUG MECHANISM; HUMAN; HUMAN CELL; IMMUNOMODULATION; MONOCYTE; MYELOMA CELL; OSTEOCLAST; OSTEOPOROSIS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; CANCER STEM CELL; CELL LINE; CHEMISTRY; COMPARATIVE STUDY; CYTOTOXICITY; DRUG EFFECT; GENE REARRANGEMENT; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; LEUKEMIA CELL LINE; LYMPHOCYTE ACTIVATION; METABOLISM; MULTIPLE MYELOMA; NEOPLASM; PATHOLOGY; SECRETION; STRUCTURE ACTIVITY RELATION; T LYMPHOCYTE SUBPOPULATION;

ALENDRONATE; ANTIGENS; CELL LINE, TRANSFORMED; CYTOTOXICITY, IMMUNOLOGIC; DIPHOSPHONATES; ETIDRONIC ACID; GENE REARRANGEMENT, DELTA-CHAIN T-CELL ANTIGEN RECEPTOR; GENE REARRANGEMENT, GAMMA-CHAIN T-CELL ANTIGEN RECEPTOR; HUMANS; INTERFERON TYPE II; INTERLEUKIN-2; JURKAT CELLS; LYMPHOCYTE ACTIVATION; MONOCYTES; MULTIPLE MYELOMA; NEOPLASMS; OSTEOCLASTS; OSTEOPOROSIS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RECOMBINANT FUSION PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; T-LYMPHOCYTE SUBSETS; TRANSFECTION; TUMOR STEM CELLS;

EID: 0035438385     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.5.1616     Document Type: Article

References (15)

1. Berenson JR, Lichtenstein A, Porter L, et al. Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study Group. N Engl J Med. 1996;334:488-493.
2. McCloskey EV, MacLennan IC, Drayson MT, et al. A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma. MRC Working Party on Leukaemia in Adults. Br J Haematol. 1998;100:317-325.
3. Rodan GA, Fleisch HA. Bisphosphonates: mechanisms of action. J Clin invest. 1996;97:2692-2696.
4. Carano A, Teitelbaum SL, Konsek JD, Schlesinger PH, Blair HC. Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro. J Clin Invest. 1990;85:456-461.
5. Kunzmann V, Bauer E, Wilhelm M. Gamma/delta T-cell stimulation by pamidronate. N Engl J Med. 1999;340:737-738.
6. Kunzmann V, Bauer E, Feurle J, et al. Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma. Blood. 2000;96:384-392.
7. Das H, Groh V, Kuijl C, et al. MICA engagement by human Vγ2Vδ2 T cells enhances their antigen-dependent effector function. Immunity. 2001;15:83-93.
8. Bukowski JF, Morita CT, Tanaka Y, et al. Vγ2Vδ2 TCR-dependent recognition of non-peptide antigens and Daudi cells analyzed by TCR gene transfer. J Immunol. 1995;154:998-1006.
9. Bukowski JF, Morita CT, Brenner MB. Human gamma delta T cells recognize alkylamines derived from microbes, edible plants, and tea: implications for innate immunity. Immunity. 1999;11:57-65.
10. Tanaka Y, Sano S, Nieves E, et al. Nonpeptide ligands for human γδ T cells. Proc Natl Acad Sci U S A. 1994;91:8175-8179.
11. van Beek E, Pieterman E, Cohen L, Lowik C, Papapoulos S. Farnesyl pyrophosphate synthase is the molecular target of nitrogen-containing bisphosphonates. Biochem Biophys Res Commun. 1999;264:108-111.
12. Morita CT, Beckman EM, Bukowski JF, et al. Direct presentation of nonpeptide prenyl pyrophosphate antigens to human γδ T cells. Immunity. 1995;3:495-507.
13. Sasaki A, Boyce BF, Story B, et al. Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice. Cancer Res. 1995;55:3551-3557.
14. Sato M, Grasser W, Endo N, et al. Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure. J Clin Invest. 1991;88:2095-2105.
15. Takahashi N, Mundy GR, Roodman GD. Recombinant human interferon-gamma inhibits formation of human osteoclast-like cells. J Immunol. 1986;137:3544-3549.